Romark Laboratories, L.C. announced today it will initiate two clinical trials of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets) for prevention of COVID-19 and other...
Mateon Therapeutics, Inc. (OTCQB:MATN) announced today it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to study its investigational...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven”) and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT...
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that the first patient was dosed...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for ECMO procedures where...
Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced the appointment of Susan McGaurn, Pharm.D. as Senior Director of Medical Affairs. In her role, Dr. McGaurn will spearhead strategic medical...
BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia’s National Unified Procurement Company (NUPCO) have signed an agreement to establish Six “Huo-Yan” (“Fire Eye”) laboratories in Saudi Arabia to fight the COVID-19...
Arcutis Pharmaceuticals, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology,...
ViiV Healthcare the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the creation of the Global HIV...
Dublin, Ireland-based Avadel Pharma announced positive topline data from its pivotal Phase III REST-ON clinical trial of FT218 for excessive daytime sleepiness and cataplexy in patients with narcolepsy. Company...
Merck is entering a collaboration agreement with the Seattle-based Institute for Systems Biology (ISB) to investigate and define the molecular activity of SARS-CoV-2 infection and COVID-19, the resulting disease. The intention...
More drugs are being assessed as potential treatments against the pandemic as the battle against COVID-19 continues. Researchers in New York are seeking to determine if...
Ortho Clinical Diagnostics has launched a new COVID-19 antibody test VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test, following the US Food and Drug Administration (FDA) Emergency Use...
Vela Diagnostics has secured CE mark approval for the manual version of the ViroKey SARS-CoV-2 RT-PCR test for in vitro diagnostic applications. The test will help...
US-based digital biology company Recursion has unveiled its open-source RxRx19 dataset, which is the first human cellular morphological dataset of SARS-CoV-2, which causes COVID-19. The company...
Copyright © 2024 Medical Buyer